Amylyx Pharmaceuticals Inc (AMLX)
NASDAQ
Quarter End | 12 2022 | 3 2023 | 6 2023 | 9 2023 | 12 2023 | 3 2024 | 6 2024 | 9 2024 |
---|---|---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | ||||
総売上 | 21.89M | 71.43M | 98.22M | 102.69M | 108.45M | 88.64M | -1.02M | 416k |
営業利益 | -44.59M | -2.05M | 20.2M | 18.72M | 1.93M | -11.67M | -68.88M | -193.53M |
税引前収入 | -42.13M | 1.4M | 24.01M | 22.41M | 6.48M | -118.55M | -72.7M | -72.7M |
純利益 | -42.7M | 1.57M | 22.07M | 20.89M | 4.73M | -118.79M | -72.7M | -72.7M |
優先配当 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
基本的1株当たり利益 (EPS) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
EBIT | -44.59M | -2.32M | 20.2M | 17.89M | 1.93M | -12.42M | -69.36M | -193.67M |
EBITDA | -44.41M | -1.85M | 20.48M | 19.02M | 2.24M | -11.35M | -68.67M | -193.31M |
年末 2023年12月31日 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
総売上 | 1.43M | 1.43M | 285k | 22.23M | 380.79M |
営業利益 | -13.55M | -13.55M | -82.69M | -201.34M | 38.8M |
税引前収入 | -13.72M | -13.72M | -87.93M | -197.6M | 54.3M |
純利益 | -13.72M | -13.72M | -87.93M | -198.38M | 49.27M |
優先配当 | 0 | 0 | 0 | 0 | 0 |
基本的1株当たり利益 (EPS) | -2.288 | -2.288 | -3.162 | -2.272 | 0.558 |
EBIT | -13.56M | -13.56M | -82.74M | -201.34M | 38.8M |
EBITDA | -13.55M | -13.55M | -82.64M | -200.85M | 39.89M |
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約